Hypothalamic involvement and insufficient sex steroid supplementation are associated with low bone mineral density in women with childhood onset craniopharyngioma

European Journal of Endocrinology

Volumn 165, Issue 1, 2011, Pages 25-31

  Holmer, Helene ^a,b   Popovic, Vera ^d   Ekman, Bertil ^c   Follin, Cecilia ^b   Siversson, Ann Britt ^b   Erfurth, Eva Marie ^b  

^a CENTRAL HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d University Clinical Center   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; GROWTH HORMONE; LEPTIN; LEVONORGESTREL; MEDROXYPROGESTERONE; NORETHISTERONE; OSTEOCALCIN; PRASTERONE; TESTOSTERONE; SEX HORMONE; HUMAN GROWTH HORMONE;

ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ANDROGEN DEFICIENCY; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCIUM INTAKE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; FEMALE; FEMUR NECK; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS DISEASE; LONG TERM CARE; LUMBAR SPINE; MALE; MENOPAUSAL SYNDROME; NEUROSURGERY; PHYSICAL ACTIVITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SKULL IRRADIATION; BRAIN REGION; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; HORMONE RESISTANCE; HYPOTHALAMUS; ONSET AGE; SCORING SYSTEM; SEX DIFFERENCE; TUMOR LOCALIZATION; BLOOD; COHORT ANALYSIS; DELAYED PUBERTY; HYPOPHYSIS TUMOR; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; BONE DENSITY; CALCIUM, DIETARY; COHORT STUDIES; CRANIOPHARYNGIOMA; FEMALE; GONADAL STEROID HORMONES; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; OSTEOCALCIN; PITUITARY NEOPLASMS; PUBERTY, DELAYED; SEX FACTORS; TESTOSTERONE;

EID: 79959463647     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0229     Document Type: Article

References (36)

1. Srinivasan S, Ogle GD, Garnett SP, Briody JN, Lee JW & Cowell CT. Features of the metabolic syndrome after childhood craniopharyngioma. Journal of Clinical Endocrinology and Metabolism 2004 89 81-86. (doi:10.1210/jc.2003- 030442)
2. Karavitaki N, Cudlip S, Adams CB & Wass JA. Craniopharyngiomas. Endocrine Reviews 2006 27 371-397. (doi:10.1210/er.2006-0002)
3. Kalapurakal JA. Radiation therapy in the management of pediatric craniopharyngiomas - a review. Child's Nervous System 2005 21 808-816. (doi:10.1007/s00381-005-1188-3)
4. Ahmet A, Blaser S, Stephens D, Guger S, Rutkas JT & Hamilton J. Weight gain in craniopharyngioma - a model for hypothalamic obesity. Journal of Pediatric Endocrinology and Metabolism 2006 19 121-127. (doi:10.1515/JPEM.2006. 19.2.121)
5. Felson DT, Zhang Y, Hannan MT & Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. Journal of Bone and Mineral Research 1993 8 567-573. (doi:10.1002/jbmr. 5650080507)
6. Hamrick MW & Ferrari SL. Leptin and the sympathetic connection of fat to bone. Osteoporosis International 2008 19 905-912. Review. (doi:10.1007/s00198-007-0487-9)
7. Roth C, Wilken B, Hanefeld F, Schröter W & Leonhardt U. Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. European Journal of Endocrinology 1998 138 89-91. (doi:10.1530/eje.0.1380089)
8. Do Prado WL, de Piano A, Lazaretti-Castro M, de Mello MT, Stella SG, Tufik S, do Nascimento CM, Oyama LM, Lofrano MC, Tock L, Caranti DA & Dâmaso AR. Relationship between bone mineral density, leptin and insulin concentration in Brazilian obeses adolscents. Journal of Bone and Mineral Metabolism 2009 27 613-619. (doi:10.1007/s00774-009-0082-6)
9. Müller HL, Schneider P, Bueb K, Etavard-Gorris N, Gebhardt U, Kolb R & Sörensen N. Volumetric bone mineral density in patients with childhood craniopharyngioma. Experimental Clinical Endocrinology and Diabetes 2003 111 168-173. (doi:10.1055/s-2003-39789)
10. Wark JD. Osteoporotic fractures: background and prevention strategies. Maturitas 1996 23 193-207. Review. (doi:10.1016/0378-5122(95)00974-4)
11. Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho- Hubner C, Shaw NJ, Dunger DB, Cheetham TD, Savage MO & Monson JP. The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. Journal of Clinical Endocrinology and Metabolism 2003881658-1663. (doi:10.1210/jc.2002-021541)
12. Boot AM, van der Sluis IM, Krenning EP & de Muinck Keizer- Schrama SM. Bone mineral density and body composition in adolescents with childhood-onset growth hormone deficiency. Hormone Research 2009 1 364-367. (doi:10.1159/000223422)
13. Holmer H, Svensson J, Rylander L, Johannsson G, Rosén T, Bengtsson BA, Thorén M, Höybye C, Degerblad M, Bramnert M, Hägg E, Engström BE, Ekman B, Thorngren KG, Hagmar L & Erfurth EM. Fracture incidence in GH-deficient patients on complete hormone replacement including GH. Journal of Bone and Mineral Research 2007 22 1842-1850. (doi:10.1359/jbmr. 070811)
14. Sävendahl L. Hormonal regulation of growth plate cartilage. Hormone Research 2005 64 (Suppl 2) 94-97. (doi:10.1159/000087764)
15. Ho KK. Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology 2007 157 695-700. (doi:10.1530/EJE-07-0631)
16. Link K, Moëll C, Garwicz S, Cavallin-Ståhl E, Björk J, Thilén U, Ahrén B & Erfurth EM. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukaemia in childhood. Journal of Clinical Endocrinology and Metabolism 2004 89 5005-5012. (doi:10.1210/jc.2004-0126)
17. Aasen G, Fagertun H & Halse J. Body composition analysis by dual X-ray absorptiometry: in vivo and in vitro comparison of three different fan-beam instruments. Scandinavian Journal of Clinical and Laboratory Investigation 2006 66 659-666. (doi:10.1080/00365510600898214)
18. Khosla S, Riggs BL, Robb RA, Camp JJ, Achenbach SJ, Oberg AL, Rouleau PA & Melton LJ III. Relationship of volumetric bone density and structural parameters at different skeletal sites to sex steroid levels in women. Journal of Clinical Endocrinology and Metabolism 2005 90 5096-5103. (doi:10.1210/jc. 2005-0396)
19. Buchanan JR, Myers C, Lloyd T, Leuenberger P & Demers LM. Determinants of peak trabecular bone density in women: the role of androgens, estrogen, and exercise. Journal of Bone and Mineral Research 1988 3 673-680. (doi:10.1002/jbmr.5650030613)
20. Wilhelmsen L, Tibblin G, Aurell M, Bjure J, Ekström-Jodal B & Grimby G. Physical activity, physical fitness and risk of myocardial infarction. Advances in Cardiology 1976 18 217-230.
21. Tudor-Locke C, Burkett L, Reis JP, Ainsworth BE, Macera CA & Wilson DK. How many days of pedometer monitoring predict weekly physical activity in adults? Preventive Medicine 2005 40 293-298. (doi:10.1016/j.ypmed.2004.06.003)
22. Eastell R & Hannon RA. Biomarkers of bone health and osteoporosis risk. Proceedings of the Nutrition Society 2008 67 157-162. (doi:10.1017/ S002966510800699X)
23. Guo Y, Zhao LJ, Shen H, Guo Y & Deng HW. Genetic and environmental correlations between age at menarche and bone mineral density at different skeletal sites. Calcified Tissue International 2005 77 356-360. (doi:10.1007/s00223-005-0181-x)
24. Finkelstein JS, Neer RM, Biller BM, Crawford JD & Klibanski AN. Osteopenia in men with a history of delayed puberty. New England Journal of Medicine 1992 326 600-604. (doi:10.1056/NEJM199202273260904)
25. Gordon CL, Halton JM, Atkinson SA & Webber CE. The contributions of growth and puberty to peak bone mass. Growth, Development, and Aging 1991 55 257-262.
26. Almstedt Shoepe H & Snow CM. Oral contraceptive use in young women is associated with lower bone mineral density than that of controls. Osteoporosis International 2005 16 1538-1544. (doi:10.1007/s00198-005-1868-6)
27. Marcus R, Leary D, Schneider DL, Shane E, Favus M & Quigley CA. The contribution of testosterone to skeletal development and maintenance: lessons from the androgen insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism 2000 85 1032-1037. (doi:10.1210/jc.85.3.1032)
28. Thienpont L, Franzini C, Kratochvila J, Middle J, Ricós C, Siekmann L & Stöckl D. Analytical quality specifications for reference methods and operating specifications for networks of reference laboratories. Discussion paper from the members of the external quality assessment (EQA) Working Group B1 on target values in EQAS. European Journal of Clinical Chemistry and Clinical Biochemistry 1995 33 949-957.
29. Frank GR. Role of estrogen and androgen in pubertal skeletal physiology. Medical and Pediatric Oncology 2003 41 217-221. (doi:10.1002/mpo.10340)
30. Mah PM, Webster J, Jönsson P, Feldt-Rasmussen U, Koltowska- Häggström M & Ross RJ. Estrogen replacement in women of fertile yr with hypopituitarism. Journal of Clinical Endocrinology and Metabolism 2005 90 5964-5969. (doi:10.1210/jc.2005-1207)
31. Gibney J, Wolthers T, Johannsson G, Umpleby M & Ho K. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men. American Journal of Physiology. Endocrinology and Metabolism 2005 589 266-271. (doi:10.1152/ajpendo.00483.2004)
32. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, Stalla GK & Ghigo E. Hypopituitarism. Lancet 2007 369 1461-1470. Review. (doi:10.1016/S0140-6736(07)60673-4)
33. Saag KG. Glucocorticoid-induced osteoporosis. Endocrinology and Metabolism Clinics of North America 2003 32 135-157. (doi:10. 1016/S0889-8529(02)00064-6)
34. Mora S, Saggion F, Russo G, Weber G, Bellini A, Prinster C & Chiumello G. Bone density in young patients with congenital adrenal hyperplasia. Bone 1996 18 337-340. (doi:10.1016/8756-3282(96)00003-8)
35. Abou Samra R, Baba NH, Torbay N, Dib L & El-Hajj Fuleihan G. High plasma leptin is not associated with higher bone mineral density in insulin-resistant premenopausal obese women. Journal of Clinical Endocrinology and Metabolism 2005 90 2588-2594. (doi:10.1210/jc.2004-2049)
36. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F & Bruner JM. The descriptive epidemiology of craniopharyngioma. Journal of Neurosurgery 1998 89 547-551. (doi:10.3171/jns.1998.89.4.0547)